)

Ascendis Pharma (ASND) investor relations material
Ascendis Pharma Wells Fargo 20th Annual Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Strategic overview and product pipeline
TransCon technology underpins internal and external product development, including collaborations in metabolic diseases and obesity.
Three independent products target major unmet medical needs, with label expansion and new chemical entities planned over the next 3–4 years.
Revenue is increasing quarter by quarter, leading to financial independence and positive cash generation.
Eight to ten product opportunities are in development, with a focus on rare disease endocrinology and future expansion into cardiovascular diseases.
Commercial infrastructure is 90% established globally, with further expansion tied to additional country launches.
Yorvu Path launch and market strategy
Yorvu Path targets hypoparathyroidism with strong IP protection through 2042 and a combination product design for long-term durability.
U.S. market expected to drive initial revenue, with ex-U.S. growth accelerating after 4–5 years as more countries come online.
Commercialization ex-U.S. follows a three-pillar strategy: direct markets, distribution agreements, and partnerships, with Japan launch imminent.
Uptake is driven by steady new prescribers and improved prescription-to-treatment infrastructure, with future growth expected from expanding prescriber base.
Barriers to treatment are low due to user-friendly delivery devices, and adherence rates are high.
Competitive landscape and product differentiation
Yorvu Path faces limited competition, with no comparable products in clinical development offering similar benefits.
Decision to launch with a daily rather than weekly formulation was based on safety, titration needs, and patient stability.
Once-weekly options may be considered for stable patients, but daily remains optimal for most.
TransCon CNP offers continuous exposure, reducing injection site reactions and hypertension risk, and shows benefits beyond linear growth, such as improved muscle strength and quality of life.
Differentiation is recognized by patients and physicians, with priority review status and plans for standard-of-care positioning.
Next Ascendis Pharma earnings date

Next Ascendis Pharma earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage